Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area

Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area

Autologous stem cell transplantation is still considered the standard of care in young patients with multiple myeloma (MM). This disease is the most common indication for high-dose therapy (HDT) supported by hematopoietic stem-cell transplantation and much data support the benefit of this procedure....

Full description

Bibliographic Details
Main Authors: Hans E. Johnsen, Bo Björkstrand, Tobias W. Klausen, Kari Remes, Astrid Gruber, Lene M. Knudsen, Olav J. Bergmann, Stig Lenhoff
Format: Article
Language:English
Published: PAGEPress Publications 2009-02-01
Series:Hematology Reports
Subjects:
Hematology
Multiple myeloma
Treatment
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/2

Similar Items

Similar Items